Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Nov 27;9(93):36645. doi: 10.18632/oncotarget.26415

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson 1, Stephen D Robinson 1, Karamallah Al-Yousuf 2,3, Adam E Hendry 1, Darren W Sexton 4,5, Victoria Sherwood 2,3, Grant N Wheeler 1
PMCID: PMC6290961  PMID: 30564304

This article has been corrected: The correct Author name is given below:

Stephen D. Robinson

Original article: Oncotarget. 2018; 9:3815-3829. https://doi.org/10.18632/oncotarget.23378


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES